A 2025 University of Helsinki study and a 24,000-dog aging project are reshaping what we know about canine nutrition. Here is what the data actually shows about kibble, raw food, and when to feed.
Read more
Bernese Mountain Dogs are known for their beauty, loyalty, and tragically short lives. With over 50% dying from cancer and an average lifespan of just 6-8 years, understanding their health challenges is essential.
Read more
As America's most popular breed, Labrador Retrievers bring joy to millions of families. But with an estimated 30% lifetime cancer rate, understanding their health vulnerabilities is essential for proactive care.
Read more
Boxers face the highest cancer mortality rate of any dog breed, with nearly half of all deaths attributed to cancer. Understanding this genetic predisposition is crucial for early detection and proactive care.
Read more
Did the surgery get it all? How to use the rapid clearance of cfDNA to check for residual disease 14 days after tumor removal.
Read more
A troubling shift has occurred in the lifespan of one of America's most beloved dog breeds. Recent research has uncovered the complex factors behind this decline and potential paths toward improvement.
Read more
Immune-Mediated Hemolytic Anemia is a thrombotic disease. We explain how 'DNA webs' (NETs) released by neutrophils fuel the fire and trigger clots.
Read more
From hit-by-cars to GDVs, necrosis releases massive amounts of DNA. How cfDNA correlates with the 'Injury Severity Score' and helps triage the multi-trauma patient.
Read more
Putting a blood tube in a styrofoam box with an ice pack is not 'preservation.' It is a recipe for lysis. We explain the thermodynamics of shipping failure.
Read more
Inflammation looks a lot like infection on a blood panel. We explore why cfDNA rises in both, and how it helps quantify the 'cytokine storm'.
Read more
A negative test doesn't guarantee health, and a positive test doesn't always mean cancer. We debunk the binary thinking that leads to clinical errors.
Read more
In the Emergency Room, we aren't looking for mutations. We are looking for the total burden of cell death. How to use cfDNA to quantify exactly how hard the patient has been hit.
Read more
It hurts to throw away a sample, but running a compromised test is worse. A checklist of 4 deal-breakers that mean you must redraw.
Read more
We can find cancer in the blood, but can we tell you where it is? We explore the current limits of localization and the future promise of methylation panels.
Read more
Fat in the blood doesn't just look bad; it scatters light and clogs filters. How lipemia distorts cfDNA values and how to handle the 'milky' sample.
Read more
Ice crystals are sharp. We explain why refreezing a plasma sample shears long DNA fragments and ruins 'integrity index' diagnostics.
Read more
Why do samples degrade after 4 hours? It's not just 'aging'—it's a biological cascade of glucose depletion and white blood cell suicide.
Read more
DNA doesn't float naked in the blood—it is wrapped around histone spools called nucleosomes. We explain why measuring the 'spool' might sometimes be better than measuring the 'thread'.
Read more
Why pink plasma leads to false negatives, and how to define rejection criteria for hemolyzed samples.
Read more
Why 'high DNA' doesn't always mean cancer, and how sensitive assays separate the tumor signal (ctDNA) from the background noise (cfDNA).
Read more
From dry ice disasters to room-temperature rules: a guide to the physics of sample stability during transit.
Read more
Using serum for cfDNA testing is the most common rookie mistake. We explain why the clotting process creates a 'genomic explosion' that invalidates results.
Read more
Standard clinic centrifuge protocols leave platelets and debris behind. Learn why the 'Double-Spin' is the mandatory standard for liquid biopsy.
Read more
Not all DNA in the blood is the same. We break down the three biological mechanisms that release DNA—programmed death, traumatic injury, and immune defense—and what they tell us about a patient's disease.
Read more
It’s not just how much DNA is in the blood, but how long the pieces are. Learn how 'fragmentomics' allows us to spot cancer even when total DNA levels are normal.
Read more
Why does a $0.50 tube ruin a $300 test? We break down the chemistry of EDTA vs. Streck tubes and help you decide which one your clinic needs.
Read more
Unlike antibodies that linger for months, cfDNA is a 'real-time' biomarker that clears in minutes. Here is how to use that speed for post-surgical monitoring and trauma triage.
Read more
How much cfDNA is too much? We review the data on healthy baselines, the impact of age and breed, and why '0.0' is not the goal.
Read more
A missed 10-minute window or a single freeze-thaw cycle can ruin a liquid biopsy. Here is the strict Standard Operating Procedure (SOP) every clinic needs.
Read more
A deep dive into the origins of cell-free DNA—apoptosis, necrosis, and NETosis—and why this 'real-time' biomarker is revolutionizing veterinary diagnostics.
Read more